Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM
The discussion shares key takeaways and practical insights for optimizing the referral and treatment process for CAR T-cell and bispecific therapies.
Video content above is prompted by the following:
Please share some key takeaways/pearls.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
